Titlebook: Genome Editing; Kursad Turksen Book 2016 Springer International Publishing Switzerland 2016 CRISPR.ESC.iPSC.nucleases.stem cells

Perforation

書目名稱Genome Editing影響因子(影響力)




書目名稱Genome Editing影響因子(影響力)學(xué)科排名




書目名稱Genome Editing網(wǎng)絡(luò)公開度




書目名稱Genome Editing網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Genome Editing被引頻次




書目名稱Genome Editing被引頻次學(xué)科排名




書目名稱Genome Editing年度引用




書目名稱Genome Editing年度引用學(xué)科排名




書目名稱Genome Editing讀者反饋




書目名稱Genome Editing讀者反饋學(xué)科排名

Omniscient

CRISPR/Cas9 Approaches to Investigate the Noncoding Genome,omologous recombination in murine ES cells. Unfortunately, the study of the noncoding fraction of the genome did not benefit from the same valuable resources. Nevertheless, increasing evidence of the relevance of this fraction of the vertebrate genome has been accumulated in the past years. Comprehe

strain

CHURL

CRISPR/Cas9 and the Paradigm Shift in Mouse Genome Manipulation Technologies,. CRISPR represents one of only a few radical and transformative shifts in transgenic technologies over the past 30 years. This chapter discusses the paradigm shift that CRISPR technology has brought about in the field of mouse genome editing.

營養(yǎng)

使痛苦

Developments in the Generation of Reporter Stem Cells,s in drug screening, basic developmental research, and potential therapeutic implementations. An emerging need in stem cell biology is efficient and homogeneous differentiation of stem cells into mature, specialized, functional cells..Reporter stem cell lines are valuable models that enable noninvas

使痛苦

Current Status of Genome Editing in Cardiovascular Medicine,the Precision Medicine Initiative in January 2015, emerging technologies such as induced pluripotent stem cells (iPSCs) and genome editing are well positioned to provide powerful tools to correlate genotypes with phenotypes. These new technologies are helping to identify specific mutations associate

縮減了

Using CRISPR-Cas9 Genome Editing to Enhance Cell Based Therapies for the Treatment of Diabetes Mellng pancreatic β-cells for diabetes treatment. To generate these cells in vitro requires a complete understanding of the normal process of pancreas development: an objective greatly aided by CRISPR-Cas9 genome-editing technology. First identified as the adaptive immune system of bacteria, CRISPR-Cas9

tooth-decay

Genome Editing in the Retina: A Case Study in CRISPR for a Patient-Specific Autosomal Dominant Retintions. The eye is an ideal target for gene therapy due to its accessibility, ease of noninvasive monitoring, significant compartmentalization, immunoprivileged status, optical transparency, and the presence of a contralateral control. One of the first gene therapy clinical trials was conducted in t

Euthyroid

978-3-319-81687-6Springer International Publishing Switzerland 2016